Kimberley Koenig

SiTime stock is in a base. The specialty semiconductor designer has produced eight straight quarters of triple-digit profit growth.

SiTime stock is in a base. The specialty semiconductor designer has produced eight straight quarters of triple-digit profit growth.

Merck stock is in a buy zone after hitting a new high. Fellow Dow stock JPMorgan Chase and Amphenol are both trading around entry points.

Biotech stock Argenx broke out of a cup-with-handle base and recently hit an all-time high. For that and other reasons, the maker of a drug to treat the autoimmune disease myasthenia gravis is Monday's IBD 50 Growth Stocks To Watch selection. The IBD 50 biotech stock was a recent IBD Stock Of The Day and also was highlighted in Thursday's IBD MarketDiem newsletter.

The Dow Jones Industrial Average and other major stock indexes were mostly lower Tuesday.

The Dow Jones Industrial Average and other major stock indexes improved from the day's lows Tuesday, even as memory-technology makers including

The Dow Jones Industrial Average and other major stock indexes weakened in the final hour of trading Tuesday, as recent tech winners Micron Technology MU and Sandisk SNDK plunged.

Glaukos stock is in the buy zone of a base. The glaucoma treatment developer raised its revenue forecast in its latest earnings report.

TSM stock is trading sideways after hitting a recent high. TSMC's profit is expected to rise 46% in its second quarter.

Financial companies and their stocks are surging back. Several stocks are in bases as investors look to more defensive and value-driven names.